Cargando…

Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results

Cystic fibrosis (CF; OMIM 219700) is a rare genetic disorder caused by a chloride channel defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L-arginine (Arg)/nitric oxide (NO) metabolism has been observed in CF patients’ lungs and in connection with malnutrition....

Descripción completa

Detalles Bibliográficos
Autores principales: Brinkmann, Folke, Hanusch, Beatrice, Ballmann, Manfred, Mayorandan, Sebene, Bollenbach, Alexander, Chobanyan-Jürgens, Kristine, Jansen, Kathrin, Schmidt-Choudhury, Anjona, Derichs, Nico, Tsikas, Dimitrios, Lücke, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356307/
https://www.ncbi.nlm.nih.gov/pubmed/32604946
http://dx.doi.org/10.3390/jcm9062012
_version_ 1783558469752717312
author Brinkmann, Folke
Hanusch, Beatrice
Ballmann, Manfred
Mayorandan, Sebene
Bollenbach, Alexander
Chobanyan-Jürgens, Kristine
Jansen, Kathrin
Schmidt-Choudhury, Anjona
Derichs, Nico
Tsikas, Dimitrios
Lücke, Thomas
author_facet Brinkmann, Folke
Hanusch, Beatrice
Ballmann, Manfred
Mayorandan, Sebene
Bollenbach, Alexander
Chobanyan-Jürgens, Kristine
Jansen, Kathrin
Schmidt-Choudhury, Anjona
Derichs, Nico
Tsikas, Dimitrios
Lücke, Thomas
author_sort Brinkmann, Folke
collection PubMed
description Cystic fibrosis (CF; OMIM 219700) is a rare genetic disorder caused by a chloride channel defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L-arginine (Arg)/nitric oxide (NO) metabolism has been observed in CF patients’ lungs and in connection with malnutrition. The aim of the present study was to investigate markers of the Arg/NO pathway in the plasma and urine of CF patients and to identify possible risk factors, especially associated with malnutrition. We measured the major NO metabolites nitrite and nitrate, Arg, a semi-essential amino acid and NO precursor, the NO synthesis inhibitor asymmetric dimethylarginine (ADMA) and its major urinary metabolite dimethylamine (DMA) in plasma and urine samples of 70 pediatric CF patients and 78 age-matched healthy controls. Biomarkers were determined by gas chromatography–mass spectrometry and high-performance liquid chromatography. We observed higher plasma Arg (90.3 vs. 75.6 µM, p < 0.0001), ADMA (0.62 vs. 0.57 µM, p = 0.03), Arg/ADMA ratio (148 vs. 135, p = 0.01), nitrite (2.07 vs. 1.95 µM, p = 0.03) and nitrate (43.3 vs. 33.1 µM, p < 0.001) concentrations, as well as higher urinary DMA (57.9 vs. 40.7 µM/mM creatinine, p < 0.001) and nitrate (159 vs. 115 µM/mM creatinine, p = 0.001) excretion rates in the CF patients compared to healthy controls. CF patients with pancreatic sufficiency showed plasma concentrations of the biomarkers comparable to those of healthy controls. Malnourished CF patients had lower Arg/ADMA ratios (p = 0.02), indicating a higher NO synthesis capacity in sufficiently nourished CF patients. We conclude that NO production, protein-arginine dimethylation, and ADMA metabolism is increased in pediatric CF patients. Pancreas and liver function influence Arg/NO metabolism. Good nutritional status is associated with higher NO synthesis capacity and lower protein-arginine dimethylation.
format Online
Article
Text
id pubmed-7356307
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73563072020-07-31 Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results Brinkmann, Folke Hanusch, Beatrice Ballmann, Manfred Mayorandan, Sebene Bollenbach, Alexander Chobanyan-Jürgens, Kristine Jansen, Kathrin Schmidt-Choudhury, Anjona Derichs, Nico Tsikas, Dimitrios Lücke, Thomas J Clin Med Article Cystic fibrosis (CF; OMIM 219700) is a rare genetic disorder caused by a chloride channel defect, resulting in lung disease, pancreas insufficiency and liver impairment. Altered L-arginine (Arg)/nitric oxide (NO) metabolism has been observed in CF patients’ lungs and in connection with malnutrition. The aim of the present study was to investigate markers of the Arg/NO pathway in the plasma and urine of CF patients and to identify possible risk factors, especially associated with malnutrition. We measured the major NO metabolites nitrite and nitrate, Arg, a semi-essential amino acid and NO precursor, the NO synthesis inhibitor asymmetric dimethylarginine (ADMA) and its major urinary metabolite dimethylamine (DMA) in plasma and urine samples of 70 pediatric CF patients and 78 age-matched healthy controls. Biomarkers were determined by gas chromatography–mass spectrometry and high-performance liquid chromatography. We observed higher plasma Arg (90.3 vs. 75.6 µM, p < 0.0001), ADMA (0.62 vs. 0.57 µM, p = 0.03), Arg/ADMA ratio (148 vs. 135, p = 0.01), nitrite (2.07 vs. 1.95 µM, p = 0.03) and nitrate (43.3 vs. 33.1 µM, p < 0.001) concentrations, as well as higher urinary DMA (57.9 vs. 40.7 µM/mM creatinine, p < 0.001) and nitrate (159 vs. 115 µM/mM creatinine, p = 0.001) excretion rates in the CF patients compared to healthy controls. CF patients with pancreatic sufficiency showed plasma concentrations of the biomarkers comparable to those of healthy controls. Malnourished CF patients had lower Arg/ADMA ratios (p = 0.02), indicating a higher NO synthesis capacity in sufficiently nourished CF patients. We conclude that NO production, protein-arginine dimethylation, and ADMA metabolism is increased in pediatric CF patients. Pancreas and liver function influence Arg/NO metabolism. Good nutritional status is associated with higher NO synthesis capacity and lower protein-arginine dimethylation. MDPI 2020-06-26 /pmc/articles/PMC7356307/ /pubmed/32604946 http://dx.doi.org/10.3390/jcm9062012 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brinkmann, Folke
Hanusch, Beatrice
Ballmann, Manfred
Mayorandan, Sebene
Bollenbach, Alexander
Chobanyan-Jürgens, Kristine
Jansen, Kathrin
Schmidt-Choudhury, Anjona
Derichs, Nico
Tsikas, Dimitrios
Lücke, Thomas
Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title_full Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title_fullStr Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title_full_unstemmed Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title_short Activated L-Arginine/Nitric Oxide Pathway in Pediatric Cystic Fibrosis and Its Association with Pancreatic Insufficiency, Liver Involvement and Nourishment: An Overview and New Results
title_sort activated l-arginine/nitric oxide pathway in pediatric cystic fibrosis and its association with pancreatic insufficiency, liver involvement and nourishment: an overview and new results
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356307/
https://www.ncbi.nlm.nih.gov/pubmed/32604946
http://dx.doi.org/10.3390/jcm9062012
work_keys_str_mv AT brinkmannfolke activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT hanuschbeatrice activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT ballmannmanfred activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT mayorandansebene activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT bollenbachalexander activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT chobanyanjurgenskristine activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT jansenkathrin activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT schmidtchoudhuryanjona activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT derichsnico activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT tsikasdimitrios activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults
AT luckethomas activatedlargininenitricoxidepathwayinpediatriccysticfibrosisanditsassociationwithpancreaticinsufficiencyliverinvolvementandnourishmentanoverviewandnewresults